You searched for "internet"
Chrome extensions
Chrome is the most popular internet browser, with 44% of the market share (April ‘19). The other browsers of relevance are: Safari (31%) and Firefox (14%). Both Chrome and Firefox can be used on PC and Mac. Safari is only...Useful, interesting, or maybe both
This column is often, but not always, about ophthalmic tech. This is one of those ‘not always’ editions. Time to share some interesting or useful things from the internet which can help in a number of ways, from preparing presentations...What's trending Oct/Nov 2025
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #AlienEarth #TheEye One of the best shows to recently start streaming is, in my opinion, Alien: Earth. The cosmic horror of...Preparing to sit the FRCOphth Part 1 as a new FY1: A modern financial, educational and AI-enhanced study guide
One week into my first year as a doctor, buried under a mountain of ward jobs, night shifts and the sheer vertical learning curve of FY1, I decided to challenge myself further: I booked the FRCOphth Part 1 exam. The...
Secondary intraocular lens implantation in children
This is a retrospective study of the medical records of children under the age of 16 who underwent secondary lens implantation for aphakic corrections after previous congenital cataract surgery over a period between January 2000 and December 2010. The study...Virtual reality pupil assessment software
For Oct/Nov 2021 we review a virtual reality (VR) solution for training and assessing pupil function. Different types of VR exist, and the application described here is used on the Oculus Quest or Pico headsets. The user wears a headset...
Post hoc analysis of the CANTREAT randomised trial
CANTREAT, a Canadian multicentre two-year randomised trial compares treat and extend treatment (T&E) relative to the monthly administration of Ranibizumab in nAMD. Two-hundred and eighty-five treatment-naïve patients with nAMD were randomised to receive either a once-monthly dosing or T&E regimen...ST1 Ophthalmology Interview Course 20 Jan 24 (Virtual)
This course is run by current trainees successful in the 2023 application cycle, with multiple members scoring 100% on the interview and ranking in the top 10 nationally. The course is designed to maximise your chances of success. Interview Course•...New Flying Eye Hospital takes to the skies for its first programme
In June of this year, international eye care charity Orbis launched their new Flying Eye Hospital, a powerful tool helping the medical community combat preventable blindness through sustainable methods. On board an MD-10 aircraft, a fully accredited ophthalmic facility can...Applying for ophthalmology ST1 in 2026: What’s new?
Competition for ophthalmology ST1 has intensified steadily over recent cycles, rising from ~9:1 (2022) to ~10:1 (2023), ~14:1 (2024) and ~22:1 (2025) [1]. Against this background, applicants benefit from a structured approach: mapping achievements to portfolio domains early, identifying gaps...
ROCK inhibition after descemetorhexis without endothelial keratoplasty: a small but timely Indian RCT
The authors present a single-centre, prospective, randomised, comparative clinical trial (RCT) of 24 eyes of 24 patients with mild-to-moderate Fuchs endothelial corneal dystrophy (FECD) undergoing combined phacoemulsification and a standardised 4mm central descemetorhexis without endothelial keratoplasty (DWEK), with or without...
